BOTACLINIC
ActiveSummary
BOTACLINIC has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €199,172 and a net result of -€30,253. Equity is growing by about 7.5% per year across the filed financial years. Its solvency ranks better than 55% of 780 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Nutrition and dietetics services
NACE 86995General medical practice NACE 86210
1 site
Size
€315,434total assets 2025
- Staff
- 1.8 FTE
- Equity
- €199,172
- Loss
- -€30,253
Why 87raises riskLoss of €30,253 (financial year 2025)lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 31-07-2026)Equity €199,172 (63.1% of total assets)Show the evidence
Checked score
Score 2025
87
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 23% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency
88-2
equity 63.1% of total assets
Liquidity
44-43
short-term debt 29.1% · cash 4.4%
Profitability
20-80
return on assets -9.6%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 6.2%
12-2024: 6.2%● unchanged vs 11-2024
01-2025: 6.2%● unchanged vs 12-2024
02-2025: 6.2%● unchanged vs 01-2025
03-2025: 6.4%▲ +0.2 percentage points vs 02-2025
04-2025: 6.4%● unchanged vs 03-2025highest value
05-2025: 6.3%▼ -0.1 percentage points vs 04-2025
06-2025: 6.2%▼ -0.1 percentage points vs 05-2025
07-2025: 6.3%▲ +0.1 percentage points vs 06-2025
08-2025: 6.3%● unchanged vs 07-2025
09-2025: 0.3%▼ -6.0 percentage points vs 08-2025
10-2025: < 0.1%▼ -0.3 percentage points vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025lowest value
12-2025: < 0.1%● unchanged vs 11-2025lowest value
01-2026: < 0.1%● unchanged vs 12-2025lowest value
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: 0.1%▲ +0.1 percentage points vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €17,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.17, compared with 2.61 in 2024, above the usual 1.5; short-term debt: 29.1% and cash: 4.4% of total assets), and 36.9% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 51% on solvency, 12% on liquidity, 5% on profitability and 25% on growth.
The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
25 days late
2023
30 days late
2022
31 days early
2021
25 days late
2020
19 days early
2019
11 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 6 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · full…
- Annual accounts filedfinancial year 2024 · full…
- Back to profitnet €1.1m
Financials · financial year 2025, full format
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€30,253
2024 · €1.1m
Working capital
€107,798▼ 24.9%
2024 · €143,508
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result turns negative in 2025: a loss of €27,917 after €1.1m in 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result-€0.03m
2025
Net result-€0.03m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€0.3m
2025
Equity€0.2m
2025
Debt€0.1m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€0.1m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)-9.6%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency63.1%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio2.17
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)1.8
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€0.09m-€0.002m▼ 98.0%€0.02m▲ 924%€0.1m▲ 433%€0.07m▼ 29.1%-€0.8m€1.1m-€0.03m
Net result€0.04m--€0.05m-€0.02mbelow the sector's middle half▲ 50.6%€0.06mwithin the sector's middle half€0.04mwithin the sector's middle half▼ 36.3%-€0.8mbelow the sector's middle half€1.1mabove the sector's middle half-€0.03mbelow the sector's middle half
Equity-€0.6m--€0.6m▼ 7.8%-€0.7mbelow the sector's middle half▼ 3.6%-€0.6mbelow the sector's middle half▲ 9.3%-€0.6mbelow the sector's middle half▲ 6.6%-€0.9mbelow the sector's middle half▼ 57.9%€0.2mwithin the sector's middle half€0.2mwithin the sector's middle half▼ 13.2%
Total assets€1.5m-€1.4m▼ 5.7%€1.3mabove the sector's middle half▼ 6.7%€1.3mabove the sector's middle half▼ 2.2%€1.2mwithin the sector's middle half▼ 5.6%€0.6mwithin the sector's middle half▼ 51.5%€0.4mwithin the sector's middle half▼ 41.2%€0.3mbelow the sector's middle half▼ 11.3%
Debt€2.1m-€2.1m▼ 1.9%€2.0m▼ 3.5%€1.9m▼ 4.5%€1.8m▼ 5.9%€1.5m▼ 17.6%€0.1m▼ 91.5%€0.1m▼ 7.9%
Working capital-€0.5m--€0.6m▼ 14.5%-€0.6mbelow the sector's middle half▲ 1.1%-€0.3mbelow the sector's middle half▲ 50.9%-€0.8mbelow the sector's middle half▼ 149%-€0.6mbelow the sector's middle half▲ 19.1%€0.1mwithin the sector's middle half€0.1mwithin the sector's middle half▼ 24.9%
Solvency-38.5%--44.0%▼ 5.5pp-48.9%below the sector's middle half▼ 4.8pp-45.3%below the sector's middle half▲ 3.6pp-44.8%below the sector's middle half▲ 0.5pp-145.8%below the sector's middle half▼ 101.0pp64.5%within the sector's middle half▲ 210.3pp63.1%within the sector's middle half▼ 1.4pp
Current ratio0.18-0.11▼ 0.070.07below the sector's middle half▼ 0.040.26below the sector's middle half▲ 0.190.11below the sector's middle half▼ 0.150.14below the sector's middle half▲ 0.032.61within the sector's middle half▲ 2.472.17within the sector's middle half▼ 0.44
Return on assets (ROA)2.5%--3.2%▼ 5.6pp-1.7%below the sector's middle half▲ 1.5pp4.7%within the sector's middle half▲ 6.3pp3.1%within the sector's middle half▼ 1.5pp-136.1%below the sector's middle half▼ 139.3pp312.5%above the sector's middle half▲ 448.6pp-9.6%below the sector's middle half▼ 322.1pp
Staff (FTE)3.3-3▼ 9.1%2.9within the sector's middle half▼ 3.3%3within the sector's middle half▲ 3.4%2.3within the sector's middle half▼ 23.3%1.8within the sector's middle half▼ 21.7%1.6below the sector's middle half▼ 11.1%1.8below the sector's middle half▲ 12.5%
above
within
below
the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €315,434
Fixed assets
€115,773 ▼ 5.8%
Current assets
€199,662 ▼ 14.2%
Equity and liabilities €315,434
Equity
€199,172 ▼ 13.2%
Debt
€116,263 ▼ 7.9%
Debt's share of the balance-sheet total rises from 35.5% to 36.9%. Equity and debt are lower.
Key figures and ratios
EBITDA
€7,225▼
2024 · €1.1m
Cash flow
€4,889▼
2024 · €1.1m
Quick ratio
2.02▼
2024 · 2.47
Debt to equity
0.58▲
2024 · 0.55
ROE
-15.2%▼
2024 · 484.3%
Interest coverage
1.53▼
2024 · over 100
Debt ≤ 1 year
€91,864▲
2024 · €89,184
Debt > 1 year
€0▼
2024 · €12,786
Income taxes
€0▼
2024 · €10,511
Staff costs
€129,828▲
2024 · €106,624
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,910 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90.9% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a small loss
1.1%
went bankrupt
7.8%
stopped otherwise
90.9%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,910 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €0.003m | €0.003m | €328 | €0 | ▼ 100% |
| Remuneration, social security and pensions62 | - | - | - | €0.1m | €0.1m | €0.1m | €0.1m | €0.1m | ▲ 21.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.08m | €0.08m | €0.09m | €0.08m | €0.06m | €0.01m | €0.02m | €0.04m | ▲ 69.2% |
| Other operating charges640/8 | - | - | - | €0.008m | €0.01m | €0.004m | €0.01m | €0.001m | ▼ 90.6% |
| Non-recurring operating charges66A | - | - | - | - | - | €1.0m | €0 | - | - |
| Gross operating margin9900 | €0.3m | €0.3m | €0.2m | €0.3m | €0.2m | €0.3m | €1.3m | €0.1m | ▼ 89.1% |
| Operating profit (loss)9901 | €0.09m | €0.002m | €0.02m | €0.1m | €0.07m | -€0.8m | €1.1m | -€0.03m | - |
| Financial income75/76B | - | - | - | €408 | €0 | €26 | €270 | €0.002m | ▲ 778% |
| Recurring financial income75 | - | €0 | €73 | €408 | €0 | €26 | €270 | €0.002m | ▲ 778% |
| Non-recurring financial income76B | - | - | - | €408 | - | - | - | - | - |
| Financial charges65/66B | - | - | - | €0.03m | €0.03m | €0.02m | €0.006m | €0.005m | ▼ 20.4% |
| Recurring financial charges65 | €0.05m | €0.05m | €0.04m | €0.03m | €0.03m | €0.02m | €0.006m | €0.005m | ▼ 20.4% |
| Profit (loss) for the period before taxes9903 | €0.04m | -€0.05m | -€0.02m | €0.06m | €0.04m | -€0.8m | €1.1m | -€0.03m | - |
| Income taxes67/77 | - | - | - | - | - | - | €0.01m | €0 | ▼ 100% |
| Profit (loss) for the period9904 | €0.04m | -€0.05m | -€0.02m | €0.06m | €0.04m | -€0.8m | €1.1m | -€0.03m | - |
| Profit (loss) for the period to be appropriated9905 | €0.04m | -€0.05m | -€0.02m | €0.06m | €0.04m | -€0.8m | €1.1m | -€0.03m | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €1.5m | €1.4m | €1.3m | €1.3m | €1.2m | €0.6m | €0.4m | €0.3m | ▼ 11.3% |
| Fixed assets21/28 | €1.4m | €1.4m | €1.3m | €1.2m | €1.1m | €0.5m | €0.1m | €0.1m | ▼ 5.8% |
| Tangible fixed assets22/27 | €1.4m | €1.4m | €1.3m | €1.2m | €1.1m | €0.5m | €0.1m | €0.1m | ▼ 5.8% |
| Land and buildings22 | - | - | - | - | - | €0.5m | €0 | - | - |
| Plant, machinery and equipment23 | - | - | - | - | - | €0.004m | €0 | - | - |
| Furniture and vehicles24 | - | - | - | €0.009m | €0.002m | €0.001m | €0.1m | €0.09m | ▼ 4.6% |
| Leasing and similar rights25 | - | - | - | €1.2m | €1.1m | €0 | - | - | - |
| Other tangible fixed assets26 | - | - | - | €0.003m | €0.002m | €0 | €0.02m | €0.02m | ▼ 10.8% |
| Financial fixed assets28 | €153 | €153 | €153 | €153 | €153 | €153 | €393 | €393 | = |
| Current assets29/58 | €0.1m | €0.08m | €0.04m | €0.1m | €0.1m | €0.1m | €0.2m | €0.2m | ▼ 14.2% |
| Stocks and contracts in progress3 | €0.04m | €0.03m | €0.02m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | ▲ 11.4% |
| Stocks30/36 | - | - | - | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | ▲ 11.4% |
| Amounts receivable within one year40/41 | €0.04m | €0.03m | €0.02m | €0.08m | €0.07m | €0.08m | €0.08m | €0.2m | ▲ 103% |
| Trade receivables40 | - | - | - | €0.08m | €0.07m | €0.08m | €0.04m | €0.02m | ▼ 36.5% |
| Other amounts receivable41 | - | - | - | - | - | - | €0.04m | €0.1m | ▲ 228% |
| Cash at bank and in hand54/58 | €0.02m | €0.01m | €0.001m | €0.01m | €0.005m | €0.003m | €0.1m | €0.01m | ▼ 89.4% |
| Deferred charges and accrued income490/1 | - | - | - | €0.006m | €0.008m | €0.007m | €0.005m | €0.002m | ▼ 50.5% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €1.5m | €1.4m | €1.3m | €1.3m | €1.2m | €0.6m | €0.4m | €0.3m | ▼ 11.3% |
| Equity10/15 | -€0.6m | -€0.6m | -€0.7m | -€0.6m | -€0.6m | -€0.9m | €0.2m | €0.2m | ▼ 13.2% |
| Contributions10/11 | €0.06m | €0.06m | €0.06m | €0.06m | €0.06m | €0.6m | €0.6m | €0.6m | = |
| Capital10 | - | - | - | €0.06m | €0.06m | €0.6m | €0.6m | €0.6m | = |
| Issued capital100 | - | - | - | €0.06m | €0.06m | €0.6m | €0.6m | €0.6m | = |
| Profit (loss) carried forward14 | -€0.7m | -€0.7m | -€0.7m | -€0.7m | -€0.6m | -€1.4m | -€0.3m | -€0.4m | ▼ 9.1% |
| Amounts payable17/49 | €2.1m | €2.1m | €2.0m | €1.9m | €1.8m | €1.5m | €0.1m | €0.1m | ▼ 7.9% |
| Amounts payable after more than one year17 | €1.4m | €1.4m | €1.3m | €1.5m | €0.9m | €0.7m | €0.01m | €0 | ▼ 100% |
| Financial debts170/4 | - | - | - | €0.3m | €0.2m | €0 | €0.01m | €0 | ▼ 100% |
| Other amounts payable178/9 | - | - | - | €1.2m | €0.8m | €0.7m | €0 | - | - |
| Amounts payable within one year42/48 | €0.7m | €0.7m | €0.7m | €0.4m | €0.9m | €0.7m | €0.09m | €0.09m | ▲ 3.0% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.2m | €0.2m | €0 | €0.01m | €0.01m | ▲ 4.7% |
| Financial debts43 | - | - | - | €0.003m | €0.003m | €0.03m | €0 | - | - |
| Credit institutions430/8 | - | - | - | €0.003m | €0.003m | €0.03m | €0 | - | - |
| Trade debts44 | €0.2m | €0.1m | €0.08m | €0.08m | €0.05m | €0.03m | €0.04m | €0.04m | ▲ 9.9% |
| Suppliers440/4 | - | - | - | €0.08m | €0.05m | €0.03m | €0.04m | €0.04m | ▲ 9.9% |
| Advances received on contracts in progress46 | - | - | - | - | - | €0.006m | €0.002m | €0.002m | = |
| Taxes, remuneration and social security45 | - | - | - | €0.06m | €0.06m | €0.05m | €0.04m | €0.04m | ▼ 4.4% |
| Taxes450/3 | - | - | - | €0.02m | €0.04m | €0.03m | €0.02m | €0.02m | ▼ 6.1% |
| Remuneration and social security454/9 | - | - | - | €0.04m | €0.03m | €0.03m | €0.01m | €0.01m | ▼ 0.9% |
| Other amounts payable47/48 | - | - | - | €0.1m | €0.6m | €0.6m | €0.001m | €0.001m | ▲ 20.0% |
| Accrued charges and deferred income492/3 | - | - | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | ▲ 0.8% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.04m | -€0.05m | -€0.02m | €0.06m | €0.04m | -€0.8m | €1.1m | -€0.03m | - |
| + Depreciation and write-downs630 | €0.08m | €0.08m | €0.09m | €0.08m | €0.06m | €0.01m | €0.02m | €0.04m | ▲ 69.2% |
| Operating cash flow (approximation) | €0.1m | €0.04m | €0.06m | €0.1m | €0.1m | -€0.8m | €1.1m | €0.005m | ▼ 99.6% |
| Investment in fixed assets (approximation) | - | -€0.04m | -€0.02m | €0.02m | -€0.001m | €0.6m | €0.4m | -€0.03m | - |
| Change in cash | - | -€0.01m | -€0.01m | €0.009m | -€0.004m | -€0.002m | €0.1m | -€0.1m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 17 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | full format | 31-07-2026 | 2026-00366601 |
| 31-12-2024 | full format | 25-08-2025 | 2025-00398138 |
| 31-12-2023 | full format | 30-08-2024 | 2024-00434918 |
| 31-12-2022 | full format | 30-06-2023 | 2023-00190620 |
| 31-12-2021 | full format | 25-08-2022 | 2022-20327874 |
| 31-12-2020 | full format | 12-07-2021 | 2021-34500367 |
| 31-12-2019 | full format | 11-08-2020 | 2020-40800031 |
| 31-12-2018 | full format | 18-07-2019 | 2019-34400140 |
| 31-12-2017 | full format | 23-08-2018 | 2018-49000589 |
| 31-12-2016 | micro format | 01-08-2017 | 2017-40100517 |
Similar companies · same sector, comparable size
PSYLABO, adviesbureau voor psychologische diagnostiek, expertise en counseling
BE 0812.302.249
Herent · equity €199,000
CATALDO MEDICALS
BE 0862.651.484
Olne · equity €199,688
THUISVERPLEGING KRIS VANHOUTTE
BE 0866.490.013
Damme · equity €198,581
Roels IT Service
BE 0809.817.663
Sint-Lievens-Houtem · equity €200,998
INSENTIS
BE 0843.791.320
Oud-Turnhout · equity €197,183
Of the 10,185 active companies whose main activity is nutrition and dietetics services (NACE 86995), figures are known for 880. 653 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
1 director, last change in 2024
Alain Bruyninckx
CurrentDirector
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
5 of this company's 9 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Alain Bruyninckx |
|
| Gregory Bertin |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
JL2A
via Alain Bruyninckx · Director
former→
Royal Football Club Liégeois
via Alain Bruyninckx · Director
former→
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
25-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 25 days late
2024
31-12
Financial
Back to profitnet €1.1m
Net result €1.1m after one loss-making year.
31-12
Financial
Liquidity more than 18 timescurrent ratio 2.61
Current ratio from 0.14 to 2.61; short-term debt falls from €715,147 to €89,184.
31-12
Financial
Equity above €200,000equity €229,425
Equity rises from -€881,758 to €229,425.
30-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 30 days late
17-07
Gazette deed
Resignation: Grégory BERTIN (director)Director discharge · Registered-office move6 facts ▸
Gazette deed
Resignation: Grégory BERTIN (director)
Director discharge · Registered-office move6 facts ▸
- General meeting, 12-06-2024
- Director resignation, Grégory BERTIN (director)
- Director discharge, Grégory BERTIN (director)
- Registered-office move, Rue Abbé Cuypers, 3 1040 Bruxelles
- Other provision, “Rue Hauster, 9 4050 Chaudfontaine” (deed in French)
- Director in office, Alain Bruyninckx (director)
2023
31-12
Financial
Weakest financial yearnet -€823,190
Net result drops to -€823,190, the lowest in the series; recovery starts the following year.
30-10
Gazette deed
Capital & sharesAuditor report · Capital increase · Capital contribution12 facts ▸
Gazette deed
Capital & shares
Auditor report · Capital increase · Capital contribution12 facts ▸
- General meeting, 04-10-2023
- Other provision, “dispense de lecture et point omis, on omet” (deed in French)
- Auditor report, EUR, “projet de rapport spécial de l’organe d’administration” (deed in French)
- Other provision, “refus bancaire pour apport d’immeuble hypothéqué, la banque pourrait demander à tout moment le remboursement intégral anticipé du crédit” (deed in French)
- Other provision, “point b) omis, on omet” (deed in French)
- Capital increase, €500,000
- Capital contribution
- Shareholding, 5000, “à compter de leur émission” (deed in French)
- Capital, €563,000 (2 times)
- Amendment of the articles
- Registered office clause, “Région bruxelloise, B-1170 Watermael-Boitsfort, chaussée de la Hulpe”, 150 (deed in French)
- Other provision, “pouvoirs d'exécution” (deed in French)
11-10
Gazette deed
Reappointments: Gregory Bertin (director) and Alain Bruyninckx (director)Registered office clause4 facts ▸
Gazette deed
Reappointments: Gregory Bertin (director) and Alain Bruyninckx (director)
Registered office clause4 facts ▸
- Registered office clause, “Chaussée de la Hulpe 150 à 1170 Watermael-Boitsfort” (deed in French)
- General meeting, 02-10-2023
- Director reappointment, Gregory Bertin (director)
- Director reappointment, Alain Bruyninckx (director)
07-09
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 16-08-2023
- Registered-office move, 1170 Watermael-Boitsfort,150 chaussée de la Hulpe
30-06
NBB filing
Annual accounts filed
financial year 2022 · full format
Show earlier events
2022
25-08
NBB filing
Annual accounts filed
financial year 2021 · full format · 25 days late
2021
31-12
Financial
Back to profitnet €61,483
Net result €61,483 after 2 loss-making years.
12-07
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
11-08
NBB filing
Annual accounts filed
financial year 2019 · full format · 11 days late
2019
18-07
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
23-08
NBB filing
Annual accounts filed
financial year 2017 · full format · 23 days late
2017
01-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 1 day late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all 17 are under Financials.
4 of 9 deeds read
About the unread acts
Of the 9 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPublic limited company
Founded19-09-2008
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
86995Nutrition and dietetics services
86109Human health activities
E-invoicing
Reachable via Peppol
Peppol ID
0208:0806466314
Registered
18-03-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 26 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Etterbeek · 1 establishment unit since 2009
Ground area
4.9 ha
Building footprint
3,379 m²
Building volume
27,073 m³
2 parcels, Brussels, Wallonia · tallest building 17.0 m. Linked by address, not a title deed.
333
companies at this address
See who is registered here
1 establishment unit
BOTACLINIC
since 2009unit no. 2.176.643.673
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 62104C0164/00F002 | Wallonia | 4.8 ha | 1 · 3,250 m² | 14.0 m · 2 |
| 21005A0542/00B006 | Brussels | 325 m² | 1 · 129 m² | 17.0 m · 5 |
How the parcels are linked
Good to know
Both parcels match the address exactly.
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- BOTACLINIC
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale, sièges administratifs,succursales,agences et comptoirs en Belgique et à l'étranger” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “2, 6 ans” (deed in French)“Termine mandat remplacé sans préjudice article 14 §5, décès,démission ou autrement” (deed in French)“Conseil élit président parmi membres, en cas d'absence ou empêchement présidé par administrateur le plus âgé” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- One provision in the deed
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Tuesday of June at 18:30
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Droits les plus étendus pour régler mode de liquidation, choisir liquidateurs et déterminer pouvoirs” (deed in French)